Jingyan Wang
Key Laboratory Of Medical Science And Laboratory Medicine Of Jiangsu Province
Zhenjiang, China
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice.
Journal: Clinical and translational medicine
Published: May 02, 2020
Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1.
Journal: Biological & pharmaceutical bulletin
Published: March 03, 2020
The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer.
Journal: Stem cells international
Published: October 30, 2019
Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect.
Journal: Clinical and translational medicine
Published: October 17, 2019
Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils.
Journal: Inflammopharmacology
Published: July 31, 2019
MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials.
Journal: American journal of translational research
Published: April 03, 2019
hucMSCs Attenuate IBD through Releasing miR148b-5p to Inhibit the Expression of 15-lox-1 in Macrophages.
Journal: Mediators of inflammation
Published: March 03, 2019
Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination.
Journal: American journal of translational research
Published: April 19, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026